Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Post by Wirtzon Mar 23, 2016 3:37am
154 Views
Post# 24691141

$31 Billion Debt??

$31 Billion Debt?? How was this possible without the Board of Directors asking some serious questions along the way as VRX acquired companies.  Seems like wreckless fudiciary practices.

I just hope my pension plans and mutuals were not holding Valeant (that realization just occurred to me).  If so, not looking forward to opening those quarterly account statements.  I already took a sizeable hit on oil, but made some back on gains in the Lithium sector - that is, Goldman Sachs "new gasoline" and on their list of 7 top future technological shifts.


wirtz.
<< Previous
Bullboard Posts
Next >>